NBY Financials
NovaBay Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$51.92M
P/E Ratio
2.6
EPS
$5.16
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-7.22M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$3.42M
Total Liabilities
$3.55M
Shareholders Equity
-
Cash & Equivalents
$430,000
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
-
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-224.4%
Net Margin
31.5%
ROE
-516.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is NBY revenue?
View NBY's income statement for detailed revenue data.
Is NBY profitable?
NBY reported a loss of $7.22M in the most recent quarter. The net profit margin is 31.5%.
What is NBY market cap?
NBY has a market capitalization of $51.92M, making it a small-cap stock.
Does NBY have debt?
View NBY's balance sheet for debt information.
What is NBY cash flow?
Cash flow data is available in the full financial statements.